Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2010
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119192A1 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
10/21/2010WO2010119191A1 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
10/21/2010WO2010119132A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus
10/21/2010WO2010119102A2 Pharmaceutical composition for treating dermatological autoimmune diseases
10/21/2010WO2010118880A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
10/21/2010WO2010118458A1 A multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical
10/21/2010WO2010096830A3 Method to treat psoriasis and other hyperproliferative skin disorders
10/21/2010WO2010091892A3 Alkylamido compounds and uses thereof
10/21/2010WO2010077101A3 Novel thiazolidinedione derivative and use thereof
10/21/2010WO2010075148A3 Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto
10/21/2010WO2010022177A3 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
10/21/2010WO2009109402A3 Composition and uses for influencing hair growth
10/21/2010US20100267842 Emulsions of Perfluorocarbons
10/21/2010US20100267841 Composition for Topical Use Containing an Extract of Stryphnodendron; Its Preparation As Well As Its Application
10/21/2010US20100267839 Diarylalkanes as potent inhibitors of binuclear enzymes
10/21/2010US20100267825 Treatment of skin damage
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267774 P38 map kinase inhibitors
10/21/2010US20100267757 Aminothiazoles and their uses
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267750 Methods and compositions for treating pain
10/21/2010US20100267746 Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267700 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
10/21/2010US20100267696 Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267683 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field
10/21/2010US20100267678 Flux-enabling compositions and methods for dermal delivery of drugs
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267667 Telomerase activating compounds and methods of use thereof
10/21/2010US20100267666 Pyrrolopyrazine kinase inhibitors
10/21/2010US20100267663 A composition for cicatrisation processes in the treatment of hypertrophic scars and for improving the biomechanical properties of the cutis
10/21/2010US20100267662 Avenanthramide-containing compositions
10/21/2010US20100267659 Extract obtained from orchidaceae plants, method for producing the extract, and external agent for skin comprising the extract
10/21/2010US20100267642 Use of complex forms of calmodulin-like skin protein clsp
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267620 Methods for slowing senescence and treating and preventing diseases associated with senescence
10/21/2010US20100266709 Compositions and Methods for Treating Burns
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266671 Device and Method for Treating Dermal Tissue
10/21/2010US20100266654 Medical composition including an extracellular matrix particulate
10/21/2010US20100266610 Auto-antibody markers of autoimmune disease
10/21/2010US20100266600 Methods of using il-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive t cells
10/21/2010US20100266583 Inhibition of il-17 production
10/21/2010US20100266572 Treatment and prevention of ischemic injury using activated protein c
10/21/2010US20100266568 Ec sod and use thereof
10/21/2010US20100266566 Treatments involving glutaredoxins and similar agents
10/21/2010US20100266553 Method for isolating and culturing adult stem cells derived from human amniotic epithelium
10/21/2010US20100266549 Novel probiotics for pet food applications
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266532 Methods for inhibiting scarring
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266516 Personal care composition
10/21/2010US20100266511 Pharmaceutical foam
10/21/2010US20100266510 Foamable Vehicle and Pharmaceutical Compositions Thereof
10/21/2010US20100266499 Cytokine receptor zcytor17 multimers
10/21/2010DE202010011556U1 Zubereitungen als Pharmazeutika, Desinfektionsmittel, Hautpflege- und Hygienemittel oder Wundtherapeutika Preparations as pharmaceuticals, disinfectants, skin care and hygiene products or wound therapeutics
10/21/2010DE202010010638U1 Nano-Hydrogele für die therapeutische und nichttherapeutische Behandlung, insbesondere zur Therapie von Stresszuständen und Regeneration Nano-hydrogels for the therapeutic and non-therapeutic treatment, in particular for the treatment of stress conditions and regeneration
10/21/2010DE102009002417A1 Verwendung organomodifizierter, im Siliconteil verzweigter Siloxane zur Herstellung kosmetischer oder pharmazeutischer Zusammensetzungen Using organically modified in Silicon part branched siloxanes for producing cosmetic or pharmaceutical compositions
10/21/2010CA2795906A1 Hpv particles and uses thereof
10/21/2010CA2761064A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
10/21/2010CA2758835A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus
10/21/2010CA2758542A1 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010CA2758538A1 Pharmaceutical composition for treating dermatological autoimmune diseases
10/21/2010CA2758359A1 Fused pyrrolopyridine derivative
10/21/2010CA2757036A1 Methionine sulfoxide peptide, compositions and methods of use
10/21/2010CA2756685A1 Emulsions of perfluorocarbons
10/20/2010EP2241560A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
10/20/2010EP2241559A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
10/20/2010EP2241351A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis
10/20/2010EP2241332A1 Therapeutic agent for pruritus
10/20/2010EP2241328A1 Interleukin-1 inhibitors in the treatment of diseases
10/20/2010EP2241320A1 Aqueous compositions containing metronidazole
10/20/2010EP2241314A1 Alpha-lipoic acid nanoparticle and method for producing the same
10/20/2010EP2241313A1 Use of flavonoids to increase the bioavailability of hesperetin
10/20/2010EP2241312A1 Use of compositions comprising urea for treating microbial infections
10/20/2010EP2240463A2 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
10/20/2010EP2240444A1 Compounds having crth2 antagonist activity
10/20/2010EP2240440A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
10/20/2010EP2240439A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
10/20/2010EP2240438A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
10/20/2010EP2240192A1 Treatment for dermatological conditions
10/20/2010EP1383513B1 Tumor therapy with sindbis virus-based vectors
10/20/2010EP1360508B1 Prediction of wound healing by urinary nitrate assay
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010CN101868235A Compositions and methods for inhibiting the activation of dsRNA-dependent protein kinase and tumor growth inhibition
10/20/2010CN101868223A Water-containing composition which can be used as external composition
10/20/2010CN101863897A New volution compound and preparation method and application thereof
10/20/2010CN101862446A SOD (Super Oxide Dismutase) grape health care wine
10/20/2010CN101862441A Liniment containing natural Zingiber corallinum Hance essential oil with functions of analgesia, antiphlogosis, detumescence and itching-relieving
10/20/2010CN101862433A Chinese medicament for treating psoriasis
10/20/2010CN101862432A Chinese medicament for treating urticaria
10/20/2010CN101862416A Itching-relieving and ringworm-eliminating liquid and preparation process thereof
10/20/2010CN101862411A Chinese medicinal composition for treating acne
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 1065